 |
- Tetranectin is a biomarker for Metabolism Syndrome, Cardiovascular Diseases and cancer research.
New Research References
Liu F, et al. The adipocyte-enriched secretory protein tetranectin exacerbates type 2 diabetes by inhibiting insulin secretion from β cells. Sci Adv. 2022 Sep 23;8(38):eabq1799. doi: 10.1126/sciadv.abq1799. Epub 2022 Sep 21. PMID: 36129988; PMCID: PMC9491725.
McDonald K, et al. Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis. Sci Rep. 2020 May 5;10(1):7507. doi: 10.1038/s41598-020-64558-4. PMID: 32371911; PMCID: PMC7200823.
Go S, et al. Adipogenic function of tetranectin mediated by enhancing mitotic clonal expansion via ERK signaling. BMB Rep. 2021 Jul;54(7):374-379. doi: 10.5483/BMBRep.2021.54.7.024. PMID: 33691910; PMCID: PMC8328820.
|
|
|
